Subject
Obstetrics and Gynecology
Reference30 articles.
1. 1. Practice Committee of the American Society for Reproductive Medicine. Electronic address: ASRM@asrm.org; Practice Committee of the American Society for Reproductive Medicine. Prevention and treatment of moderate and severe ovarian hyperstimulation syndrome: a guideline. Fertil Steril 2016;106:1634-47.
2. 2. Mourad S, Brown J, Farquhar C. Interventions for the prevention of OHSS in ART cycles: an overview of Cochrane reviews. Cochrane Database Syst Rev 2017;1:CD012103.
3. 3. Surcel M, Surcel M, Zlatescu-Marton C, Micu R, Nemeti GI, Axente DD, et al. The role of high follicular levels of angiotensin II and vascular endothelial growth factor in antipating the development of severe ovarian hyperstimılation syndrome in patients with prophylactic cabergoline therapy undergoing an in vitro fertilization procedure. Acta Endocrinol (Buchar) 2020;16:30-6.
4. 4. Duffy DM, Ko C, Jo M, Brannstrom M, Curry TE. Ovulation: Parallels With Inflammatory Processes. Endocr Rev 2019;40:369-416.
5. 5. Manau D, Fabregues F, Penarrubia J, Creus M, Carmona F, Casals G, et al. Vascular endothelial growth factor levels in serum and plasma from patients undergoing controlled ovarian hyperstimulation for IVF. Hum Reprod 2007;22:669-75.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献